Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment

This policy article (A56943) provides billing and coding guidance that complements the MolDX LCD L36129 for biomarkers in cardiovascular risk assessment and does not itself define clinical coverage criteria. For covered indications, medical necessity, frequency limits, and specific testing criteria, consult LCD L36129; this article should be used only to inform billing and coding practices in conjunction with that LCD.

"This article does not establish clinical coverage or medical necessity criteria; all coverage decisions are governed by LCD L36129 (MolDX: Biomarkers in Cardiovascular Risk Assessment)."

Sign up to see full coverage criteria, indications, and limitations.